← Back to Clinical Trials
Recruiting NCT03772119

NCT03772119 Assessment and Follow-up of Surgical Treatment of Hemivertebra in Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03772119
Status Recruiting
Phase
Sponsor University Hospital, Tours
Condition Hemivertebra
Study Type OBSERVATIONAL
Enrollment 150 participants
Start Date 2019-02-04
Primary Completion 2039-02

Eligibility & Interventions

Sex All sexes
Min Age 3 Years
Max Age 10 Years
Study Type OBSERVATIONAL
Interventions
Surgical resection

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 150 participants in total. It began in 2019-02-04 with a primary completion date of 2039-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The treatment of child's vertebral malformations has evolved a lot including the realization of surgical vertebral resections. The surgical techniques used are multiple, require heavy surgery, one or more approaches and surgical time, transfusions, a neurological risk (up to 20% in some series, risk of non-consolidation, insufficient correction). These surgical techniques deserve an evaluation of the early complications and the skeletal maturity of these children (maintenance of the surgical correction, evolution of the associated curvatures).

Eligibility Criteria

Inclusion Criteria: * Child from 3 to 10 years old * with a vertebral malformation requiring surgery for hemivertebras Exclusion Criteria: * Child previously operated on the spine * Different procedure of a surgical resection of vertebral malformation * Absence of medical follow-up * Parents refusal concerning data storage

Contact & Investigator

Central Contact

Thierry ODENT, MD-PhD

✉ T.ODENT@chu-tours.fr

📞 02 47 47 38 22

Principal Investigator

Thierry ODENT, MD-PhD

STUDY DIRECTOR

University Hospttal, Tours

Frequently Asked Questions

Who can join the NCT03772119 clinical trial?

This trial is open to participants of all sexes, aged 3 Years or older, up to 10 Years, studying Hemivertebra. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT03772119 currently recruiting?

Yes, NCT03772119 is actively recruiting participants. Contact the research team at T.ODENT@chu-tours.fr for enrollment information.

Where is the NCT03772119 trial being conducted?

This trial is being conducted at Bordeaux, France, Grenoble, France, Lyon, France, Marseille, France and 9 additional locations.

Who is sponsoring the NCT03772119 clinical trial?

NCT03772119 is sponsored by University Hospital, Tours. The principal investigator is Thierry ODENT, MD-PhD at University Hospttal, Tours. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology